Su JG - Search Results

1

AKT mediates actinomycin D-induced p53 expression.

Chen CS, Ho DR, Chen FY, Chen CR, Ke YD, Su JG. Chen CS, et al. Among authors: su jg. Oncotarget. 2014 Feb 15;5(3):693-703. doi: 10.18632/oncotarget.1328. Oncotarget. 2014. PMID: 24525337 Free PMC article.

2

2,3,7,8-Tetrachlorodibenzo-p-dioxin's suppression of 1-nitropyrene-induced p53 expression is mediated by cytochrome P450 1A1.

Su JG, Huang MC, Chen FY. Su JG, et al. Chem Res Toxicol. 2011 Dec 19;24(12):2167-75. doi: 10.1021/tx200309p. Epub 2011 Nov 14. Chem Res Toxicol. 2011. PMID: 22044530

3

Cyprodinil as an activator of aryl hydrocarbon receptor.

Fang CC, Chen FY, Chen CR, Liu CC, Wong LC, Liu YW, Su JG. Fang CC, et al. Among authors: su jg. Toxicology. 2013 Feb 8;304:32-40. doi: 10.1016/j.tox.2012.11.018. Epub 2012 Dec 7. Toxicology. 2013. PMID: 23228475

4

Activation of aryl hydrocarbon receptor reduces carbendazim-induced cell death.

Wei KL, Chen FY, Lin CY, Gao GL, Kao WY, Yeh CH, Chen CR, Huang HC, Tsai WR, Jong KJ, Li WJ, Su JG. Wei KL, et al. Among authors: su jg. Toxicol Appl Pharmacol. 2016 Sep 1;306:86-97. doi: 10.1016/j.taap.2016.06.004. Epub 2016 Jun 7. Toxicol Appl Pharmacol. 2016. PMID: 27286660

5

Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus.

Shao S, Zhang XF, Hou JW, Yang SS, Han ZB, Wu HL, Tang F, Li XY, Lei ZH, Zhao ZX, Li SX, Liu ZM, Shan P, Jin YQ, Su JG, Liang Y, Zhang J, Li QM. Shao S, et al. Among authors: su jg. NPJ Vaccines. 2024 Mar 19;9(1):62. doi: 10.1038/s41541-024-00855-7. NPJ Vaccines. 2024. PMID: 38503757 Free PMC article.

6

Global Burden of Chronic Obstructive Pulmonary Disease Through 2050.

Boers E, Barrett M, Su JG, Benjafield AV, Sinha S, Kaye L, Zar HJ, Vuong V, Tellez D, Gondalia R, Rice MB, Nunez CM, Wedzicha JA, Malhotra A. Boers E, et al. Among authors: su jg. JAMA Netw Open. 2023 Dec 1;6(12):e2346598. doi: 10.1001/jamanetworkopen.2023.46598. JAMA Netw Open. 2023. PMID: 38060225 Free PMC article.

7

Etoricoxib enhances aryl hydrocarbon receptor activity.

Fang HH, Hsu J, Su JJ. Fang HH, et al. Toxicology. 2023 Nov;499:153658. doi: 10.1016/j.tox.2023.153658. Epub 2023 Oct 26. Toxicology. 2023. PMID: 37890551

8

Chimeric virus-like particles of human norovirus constructed by structure-guided epitope grafting elicit cross-reactive immunity against both GI.1 and GII.4 genotypes.

Hou YN, Jin YQ, Zhang XF, Tang F, Hou JW, Liu ZM, Han ZB, Zhang H, Du LF, Shao S, Su JG, Liang Y, Zhang J, Li QM. Hou YN, et al. Among authors: su jg. J Virol. 2023 Oct 31;97(10):e0093823. doi: 10.1128/jvi.00938-23. Epub 2023 Oct 4. J Virol. 2023. PMID: 37792003 Free PMC article.

9

Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer.

Chen PC, Ning Y, Li H, Su JG, Shen JB, Feng QC, Jiang SH, Shi PD, Guo RS. Chen PC, et al. Among authors: su jg. Cell Oncol (Dordr). 2024 Feb;47(1):81-96. doi: 10.1007/s13402-023-00852-3. Epub 2023 Aug 22. Cell Oncol (Dordr). 2024. PMID: 37606818

10

Identification of key mutations responsible for the enhancement of receptor-binding affinity and immune escape of SARS-CoV-2 Omicron variant.

Wang WB, Ma YB, Lei ZH, Zhang XF, Li J, Li SS, Dong ZY, Liang Y, Li QM, Su JG. Wang WB, et al. Among authors: su jg. J Mol Graph Model. 2023 Nov;124:108540. doi: 10.1016/j.jmgm.2023.108540. Epub 2023 Jun 9. J Mol Graph Model. 2023. PMID: 37352723 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page